Eli Lilly-partnered TRexBio will apply the IPO proceeds toward clinical development of molecules designed to activate regulatory T cells to mediate immune responses and inflammation. Meanwhile, ...

Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say ...

The pace of change in digital innovation has exposed the ever-widening gap between digital health and Pharma commercial teams ...

Earlier detection is valuable, but it creates a duty that does not end when an alert appears in the electronic health record.

The Series A round was led by Oak HC/FT, with participation from Norwest, .406 Ventures, Constellation Ventures, Y Combinator ...

Cybersecurity leaders discussed how AI-driven cybersecurity attacks pose a new level of risk for hospitals and health systems ...

Fraud, waste, and abuse (FWA) continue to challenge dental plans as overtreatment, miscoding and inappropriate billing ...

Nobody has ever needed convincing on what to fix. What they've lacked is a way to act on it themselves, in something close to ...

Trilliant Health’s report identifies six trends highlighting how misaligned incentives are contributing to rising costs, poor ...

Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the ...

Launched last week, Facktor Ventures, an early-stage venture fund is taking a new approach to healthcare investing: they’re ...

The Trump administration is issuing one-time $90 payments to more than 20 million Medicare beneficiaries to help cover Part B premiums, though the payments may do little to offset rising healthcare ...